Ginkgo Bioworks Holdings, Inc.
General ticker "DNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $554.0M (TTM average)
Ginkgo Bioworks Holdings, Inc. follows the US Stock Market performance with the rate: 27.5%.
Estimated limits based on current volatility of 4.6%: low 7.56$, high 8.29$
Factors to consider:
- Total employees count: 834 (-31.5%) as of 2024
- Top business risk factors: Cost increases, Customer dependency, Organizational changes, Litigation risks, Acquisition/divestiture risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.74$, 14.80$]
- 2026-12-31 to 2027-12-31 estimated range: [5.07$, 13.32$]
Financial Metrics affecting the DNA estimates:
- Positive: with PPE of -1.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -36.69 <= 0.07
- Positive: 42.60 < Shareholder equity ratio, % of 45.42 <= 64.25
Short-term DNA quotes
Long-term DNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $251.46MM | $227.04MM | $170.16MM |
| Operating Expenses | $1,115.86MM | $786.80MM | $485.43MM |
| Operating Income | $-864.41MM | $-559.76MM | $-315.28MM |
| Non-Operating Income | $-28.53MM | $12.25MM | $1.68MM |
| Interest Expense | $0.09MM | $0.09MM | $0.00MM |
| R&D Expense | $580.62MM | $424.06MM | $243.77MM |
| Income(Loss) | $-892.94MM | $-547.51MM | $-313.60MM |
| Taxes | $-0.07MM | $-0.48MM | $-0.84MM |
| Profit(Loss)* | $-892.87MM | $-547.03MM | $-312.76MM |
| Stockholders Equity | $1,097.15MM | $716.06MM | $508.59MM |
| Inventory | $0.05MM | $0.00MM | $0.00MM |
| Assets | $1,665.34MM | $1,377.45MM | $1,119.70MM |
| Operating Cash Flow | $-295.50MM | $-319.58MM | $-171.06MM |
| Capital expenditure | $40.80MM | $62.54MM | $7.67MM |
| Investing Cash Flow | $-80.69MM | $-62.24MM | $-240.29MM |
| Financing Cash Flow | $-3.22MM | $-1.74MM | $17.77MM |
| Earnings Per Share** | $-18.40 | $-10.54 | $-5.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.